Frontline ALK, EGFR Inhibition in Non-Small Cell Lung Cancer
0 Views
administrator
07/14/23
Panelists discuss the frontline administration of ALK and EGFR inhibitors for patients with advanced non-small cell lung caner.
For more from this discussion, visit http://www.onclive.com/peer-exchange/nsclc-needs
-
Category
Show more
Facebook Comments
No comments found